Global Minimally Invasive Surgical Systems Market (2021-2031)

DUBLIN, September 15, 2021 / PRNewswire / – The report “Global Minimally Invasive Surgical Systems Market: Focus on Product Type, Application, End Users, 25 Country Data, Patent Scenario, and Competitive Landscape – Analysis and Forecast , 2021-2031 »has been added to ResearchAndMarkets.com offer.

The global minimally invasive surgical systems market is estimated at $ 27,882.8 million in 2020 and should reach $ 55,716.7 million by the end of 2031, with a CAGR of 6.3% in 2021-2031.

Key questions answered in the report

  • What are the major regulations governing the minimally invasive surgical systems market globally?
  • What are the key technological developments on which current industry leaders devote most of their research and development (R&D) investments?
  • How is the role of minimally invasive surgery technologies expected to evolve in the future?
  • Who are the major players who currently hold significant dominance in the global minimally invasive surgical systems market?
  • How likely are current business models to continue into the future?
  • What are the main drivers, challenges, growth opportunities and market trends?
  • How do minimally invasive procedures work in relation to each other?
  • How is patent expiration likely to disrupt market dynamics?
  • What are the key strategies integrated by the main players in the landscape of minimally invasive surgical systems?
  • What is the likelihood of new players entering the market in the short term?
  • What is the current revenue contribution of different endoscopes and endoscopy systems, and what changes are expected during the forecast period?
  • What is the current revenue contribution of different types of conventional minimally invasive surgical systems and what changes are expected during the same forecast period?
  • What is the current revenue contribution of different types of surgical robotic systems and what changes are expected during the same forecast period?
  • Which countries are contributing most of the current demand and which countries have a significant margin of business expansion activity, by major players?

According to the National Cancer Institute, minimally invasive surgery is defined as “surgery that is done using small incisions (cuts) and a few stitches. During minimally invasive surgery, one or more small incisions may be made in the body. A laparoscope (thin, tube-shaped instrument with a lumen and a lens for viewing) is inserted through an opening to guide the surgery. Tiny surgical instruments are inserted through other openings to perform the surgery. Minimally invasive surgery can cause less pain, scarring and damage to healthy tissue, and the patient can recover faster than with traditional surgery. “

According to the United States Food and Drug Administration (FDA), “Different types of computer-assisted surgical systems can be used for preoperative planning, surgical navigation, and to aid in performing surgical procedures. Robot-assisted surgical devices (RAS) are one of them. type of computer-assisted surgical system. Sometimes called robotic surgery, RAS devices allow the surgeon to use computer and software technology to control and move surgical instruments through one or more small incisions in the patient’s body (minimally invasive) for a variety of surgical procedures. “

Impact of COVID-19

The COVID-19 pandemic has had a huge impact on elective surgeries in the first half of 2020. The COVID-19 pandemic has had a huge impact on the daily routine services of hospitals globally. During the initial phase of the pandemic, hospitals significantly reduced or canceled elective surgeries for patient safety and to prioritize care treatments for patients with COVID-19.

The reduction in the volume of large-scale elective surgeries has had a substantial impact on patients as well as a financial impact on medical device manufacturers. This has resulted in lower sales of minimally invasive surgical systems.

Key Market Players and Competition Summary

Some of the major players operating in the market include Arthrex Inc., Asensus Surgical, Inc., Boston Scientific Corporation, Conmed Corporation, Fujifilm Holdings Corporation, Intuitive Surgical, Inc., Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Hoya Corporation (Pentax Medical), Siemens Healthineers AG, Smith & Nephew plc, Sony Corporation, Stryker Corporation and Zimmer Biomet Holdings, Inc.

The market for minimally invasive surgical systems has seen several strategic and technological developments of january 2017July 2021, undertaken by the various market players to achieve their respective market shares in this emerging field. Some of the strategies covered in this segment are product development and upgrades, partnerships, collaborations, business expansions, financing activities, regulatory approvals, mergers and acquisitions. The preferred strategy of companies has been partnerships, collaborations and business expansions.

Main topics covered:

1 Market definition and field of study

2 markets
2.1 Global Market Outlook (Million USD)
2.2 Key enabling technologies
2.2.1 Growing adoption of 4K Imaging technologies
2.2.2 Haptics in minimally invasive surgical technologies
2.2.3 Artificial intelligence in minimally invasive surgical technologies
2.2.4 The advent of miniature minimally invasive surgical instruments
2.3 Business model analysis
2.4 Patent landscape
2.4.1 Conventional minimally invasive technologies
2.4.2 Minimally invasive surgical robotics
2.4.3 Impact of patent expiration
2.5 Market dynamics
2.5.1 Overview
2.5.2 Impact assessment
2.5.3 Market Drivers
2.5.3.1 Growing Incidence of Chronic Diseases
2.5.3.2 Advantages over open surgeries
2.5.3.3 Increase in the global geriatric population
2.5.3.4 Increased health care costs
2.5.3.5 Technological advancement in minimally invasive surgical procedures and technologies
2.5.4 Market restrictions
2.5.4.1 High cost of minimally invasive surgical robotic systems
2.5.4.2 Shortage of qualified professionals
2.5.4.3 Restrictive reimbursement landscape
2.5.5 Market opportunities
2.5.5.1 Engage in mergers and acquisitions to diversify the endoscopic portfolio
2.5.5.2 Development of surgical simulators for training professionals
2.5.5.3 Development of low cost surgical robotic systems
2.5.6 Market Trends
2.5.6.1 Operating lease programs implemented by manufacturers of surgical robots
2.6 Industry Opportunity Analysis
2.7 Supply chain analysis
2.8 Impact of the COVID-19 pandemic
2.8.1 Pre-COVID-19 scenario
2.8.2 Post-COVID-19 scenario
2.9 Analyst’s point of view

3 Application
3.1 Global Minimally Invasive Surgical Systems Market (by Application)
3.1.1 Overview
3.1.2 Opportunity assessment
3.1.3 Market attractiveness analysis
3.1.4 Market Size and Forecast
3.1.4.1 Minimally invasive conventional technologies
3.1.4.1.1 General surgery
3.1.4.1.2 Urological surgery
3.1.4.1.3 Gynecological surgery
3.1.4.1.4 Orthopedic surgery
3.1.4.1.5 Cardiovascular surgery
3.1.4.1.6 Neurosurgery
3.1.4.1.7 Others
3.1.4.2 Minimally invasive surgical robotics
3.1.4.2.1 General surgery
3.1.4.2.2 Urologic surgery
3.1.4.2.3 Gynecological surgery
3.1.4.2.4 Orthopedic surgery
3.1.4.2.5 Cardiovascular surgery
3.1.4.2.6 Neurosurgery
3.1.4.2.7 Others
3.2 Global Minimally Invasive Surgical Systems Market (by End User)
3.2.1 Overview
3.2.2 Opportunity assessment
3.2.3 Market attractiveness analysis
3.2.4 Market Size and Forecast
3.2.4.1 Minimally invasive conventional technologies
3.2.4.1.1 Hospitals
3.2.4.1.2 Ambulatory surgery centers (ASC)
3.2.4.1.3 Specialized clinics
3.2.4.2 Minimally invasive surgical robotics
3.2.4.2.1 Hospitals
3.2.4.2.2 Outpatient surgical centers (ASCs)
3.2.4.2.3 Specialized clinics

4 Product

5 Region

6 Competitive benchmarking and company profiles
6.1 Competitive benchmarking
6.1.1 Market share analysis
6.1.1.1 Conventional minimally invasive technologies
6.1.1.2 Minimally invasive surgical robotics
6.1.2 Strategies and key developments (transaction monitoring)
6.1.2.1 Conventional minimally invasive technologies
6.1.2.1.1 Partnerships, alliances and business expansion
6.1.2.1.2 New offers and upgrades
6.1.2.1.3 Mergers and acquisitions (M&A) activities
6.1.2.1.4 Regulatory and legal activities
6.1.2.1.5 Fundraising activities
6.1.2.2 Minimally invasive surgical robotics
6.1.2.2.1 Partnerships, alliances and business expansions
6.1.2.2.2 New offers and upgrades
6.1.2.2.3 Mergers and acquisitions (M&A) activities
6.1.2.2.4 Regulatory and legal activities
6.1.2.2.5 Fundraising activities
6.1.3 Competitor snapshot
6.2 Company profiles
6.2.1 Presentation
6.2.2 Arthrex inc.
6.2.2.1 Company outlook
6.2.2.2 Role of the Company
6.2.2.3 Product portfolio
6.2.2.4 Competitive analysis
6.2.2.4.1 Strengths of the Company
6.2.2.4.2 Weakness of the Company
6.2.3 Asensus Surgical, Inc.
6.2.4 Boston Scientific Society
6.2.5 Conmed Company
6.2.6 Fujifilm Holdings Corporation
6.2.7 Intuitive Surgical, Inc.
6.2.8 Karl Storz SE & Co. KG
6.2.9 Medtronic plc
6.2.10 Olympe Society
6.2.11 Hoya Corporation (Pentax Medical)
6.2.12 Siemens Healthineers SA
6.2.13 Smith & Nephew plc
6.2.14 Sony Corporation
6.2.15 Product portfolio
6.2.16 Stryker Company
6.2.17 Zimmer Biomet Holdings, Inc.

7 Research methodology

For more information on this report, visit https://www.researchandmarkets.com/r/d4b4z8

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716

SOURCE Research and Markets

Related links

http://www.researchandmarkets.com

Comments are closed.